2021 Doctoral Fellows
Over the course of 3 years we have recruited 8 fellows under the atchivr program. 4 Doctoral Fellows and 4 Post-Doctoral Fellows.
2021 Doctoral Fellows

Tafadzwa Madanhire, MSc (University of Zimbabwe 2018).
D43 Doctoral fellow
Is biostatistician by training from the University of Zimbabwe currently supporting observational and longitudinal musculoskeletal studies at Biomedical Research and Training Institute (BRTI). He is involved in developing statistical plans and performing the subsequent analyses for various HIV based projects at BRTI. He registered as a PhD research fellow at LSHTM with interests in HIV, modelling mechanistic bone pathways and skeletal growth in children. He was awarded a full scholarship for his Masters in Biostatistics by Tackling Infections to Benefit Africa (TIBA) organisation. He is affiliated to (1) Biomedical Research and Training Institute; (2) University of Bristol, Bristol Medical School, Musculoskeletal Research Unit; (3) University of the Witwatersrand, Johannesburg, School of Clinical Medicine, Faculty of Health Sciences
Meet Tafadzwa

Justin Mayini, MSc (National University of Science and Technology, Zimbabwe 2019)
D43 Doctoral fellow
Justin Mayini is a Laboratory Scientist at BRTI with over 15 years of working experience in various capacities ranging from molecular diagnostics, serology, microbiology, Quality Systems Management etc. He holds a Masters’ Degree in Microbiology & Biotechnology with NUST (2019). Further knowledge and skills have been acquired through numerous professional developmental courses locally and internationally and by virtue of his work experiences in BRTI and its collaborative Institutions. Justin is passionate about molecular diagnostics especially in HIV-1 genomics, drug resistance and biomarker discovery. Currently, he is mostly involved in HIVDR testing, evaluating molecular tests kits and testing of Covid19 using RT-PCR. For his Phd work intends to cover the analysis of anti-HIV-1 miRNAs expression profiles in plasma of HIV-1 infected adults as a biomarker for treatment and HIV drug resistance in Zimbabwe